These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 8725703)
1. Use of depot medroxyprogesterone acetate contraception in adolescents. Davis AJ J Reprod Med; 1996 May; 41(5 Suppl):407-13. PubMed ID: 8725703 [TBL] [Abstract][Full Text] [Related]
2. Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population. Polaneczky M; Guarnaccia M; Alon J; Wiley J Fam Plann Perspect; 1996; 28(4):174-8. PubMed ID: 8853283 [TBL] [Abstract][Full Text] [Related]
3. Counseling issues and management of side effects for women using depot medroxyprogesterone acetate contraception. Nelson AL J Reprod Med; 1996 May; 41(5 Suppl):391-400. PubMed ID: 8725701 [TBL] [Abstract][Full Text] [Related]
4. Depo Provera. Position paper on clinical use, effectiveness and side effects. Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658 [TBL] [Abstract][Full Text] [Related]
9. Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer. Kaunitz AM J Reprod Med; 1996 May; 41(5 Suppl):419-27. PubMed ID: 8725705 [TBL] [Abstract][Full Text] [Related]
10. A comparison of levonorgestrel implants with depo-medroxyprogesterone acetate injections for contraception. London RS J SOGC; 1993 Oct; 15(8):925-8, 32. PubMed ID: 12318530 [TBL] [Abstract][Full Text] [Related]
11. Long-acting hormonal contraception: assessing impact on bone density, weight, and mood. Kaunitz AM Int J Fertil Womens Med; 1999; 44(2):110-7. PubMed ID: 10338269 [TBL] [Abstract][Full Text] [Related]
12. Characteristics of injectable contraceptive users in a low-income population in Texas. Sangi-Haghpeykar H; Poindexter AN; Moseley DC; Bateman L; Reid ED Fam Plann Perspect; 1995; 27(5):208-11, 225. PubMed ID: 9104608 [TBL] [Abstract][Full Text] [Related]
13. A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception. Cromer BA; Smith RD; Blair JM; Dwyer J; Brown RT Pediatrics; 1994 Nov; 94(5):687-94. PubMed ID: 7936897 [TBL] [Abstract][Full Text] [Related]
14. Preventing repeat teen pregnancy: postpartum depot medroxyprogesterone acetate, oral contraceptive pills, or the patch? Thurman AR; Hammond N; Brown HE; Roddy ME J Pediatr Adolesc Gynecol; 2007 Apr; 20(2):61-5. PubMed ID: 17418388 [TBL] [Abstract][Full Text] [Related]
15. Program- and method-related determinants of first DMPA use duration in rural Bangladesh. Riley AP; Stewart MK; Chakraborty J Stud Fam Plann; 1994; 25(5):255-67. PubMed ID: 7871551 [TBL] [Abstract][Full Text] [Related]
16. Depot medroxyprogesterone acetate contraception in women with medical problems. Frederiksen MC J Reprod Med; 1996 May; 41(5 Suppl):414-8. PubMed ID: 8725704 [TBL] [Abstract][Full Text] [Related]
18. Depot medroxyprogesterone acetate: implications for weight status and bone mineral density in the adolescent female. Bonny AE; Harkness LS; Cromer BA Adolesc Med Clin; 2005 Oct; 16(3):569-84. PubMed ID: 16183540 [TBL] [Abstract][Full Text] [Related]
19. Depo-Provera in adolescents: effects of early second injection or prior oral contraception. Harel Z; Biro FM; Kollar LM J Adolesc Health; 1995 May; 16(5):379-84. PubMed ID: 7662688 [TBL] [Abstract][Full Text] [Related]
20. Medroxyprogesterone acetate as an injectable contraceptive. Heber KR Aust Fam Physician; 1988 Mar; 17(3):199-201, 204. PubMed ID: 2965570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]